About Maiva Pharma
Maiva Pharma is a company based in Hosur (India) founded in 1996. Maiva Pharma has raised $124.83 million across 7 funding rounds from investors including Morgan Stanley, PharmaScience and Mahaganapati Advisors. The company has 751 employees as of April 03, 2024. Maiva Pharma offers products and services including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study. Maiva Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hosur, India
- Employees 751 as on 03 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Maiva Pharma Private Limited
- Date of Incorporation 05 Feb, 1993
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
$25.52 M (USD)0as on Mar 31, 2023
-
Net Profit
$4.38 M (USD)0as on Mar 31, 2023
-
EBITDA
$6.95 M (USD)0as on Mar 31, 2023
-
Total Equity Funding
$124.83 M (USD)
in 7 rounds
-
Latest Funding Round
$119.8 M (USD), Unspecified
Apr 30, 2024
-
Investors
Morgan Stanley
& 8 more
-
Employee Count
751
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Maiva Pharma
Maiva Pharma offers a comprehensive portfolio of products and services, including Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study.
Manufactures sterile liquid pharmaceuticals for medical use.
Produces freeze-dried pharmaceutical products for stability.
Conducts studies to assess material safety in pharmaceuticals.
Evaluates container integrity for pharmaceutical applications.
Analyzes impurities to meet pharmaceutical standards.
People of Maiva Pharma
Unlock access to complete
Leadership Team
2 people
Lead Team
1 people
Assistant Team
1 people
Senior Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of Maiva Pharma
Maiva Pharma has successfully raised a total of $124.83M across 7 strategic funding rounds. The most recent funding activity was a Unspecified round of $119.8 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Maiva Pharma
Maiva Pharma has secured backing from 9 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Morgan Stanley, PharmaScience and Mahaganapati Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Locked | Locked | Locked | |
|
Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets.
|
Locked | Locked | Locked | |
|
Business advisory consulting services are provided to various clients.
|
Locked | Locked | Locked |
Investor details for Maiva Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Maiva Pharma
Investment portfolio details for Maiva Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Maiva Pharma
Detailed financials for Maiva Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Maiva Pharma Comparisons
Peer comparison for Maiva Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Maiva Pharma
Maiva Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Maiva Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Maiva Pharma
Complete news archive for Maiva Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maiva Pharma
Maiva Pharma was founded in 1996 and raised its 1st funding round 13 years after it was founded.
Maiva Pharma is headquartered in Hosur, India. It is registered at Hosur, Tamil Nadu, India.
Bhaskar Krishna Arumugam is the current CEO of Maiva Pharma.
Maiva Pharma is a funded company, having raised a total of $124.83M across 7 funding rounds to date.
As of Apr 03, 2024, the latest employee count at Maiva Pharma is 751.
Annual revenue of Maiva Pharma is $25.52M as on Mar 31, 2023.
Maiva Pharma was founded in 1996 and is based in Hosur, India. Operations focus on the pharmaceutical sector, where formulation development and analytical method validation services are offered. Injectable supply services are also managed to support manufacturing needs. The company serves clients through these core activities in a specialized environment.
Maiva Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Maiva Pharma offers Sterile Liquid Products, Lyophilized Products, Extractables and Leachable Study, Delamination Study, and Elemental Impurities Study.
Maiva Pharma has 9 investors. Key investors include Morgan Stanley, PharmaScience, Mahaganapati Advisors, Anna Thomas Chacko, and T Thomas.
The valuation of Maiva Pharma is $13.6M as of Mar 2016.